The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers

A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

HL Elliott, PA Meredith, DJ Sumner et al. · British Journal of Clinical Pharmacology · 1982 · 86 citations · Full text

A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.

M.H. Frick, P Halttunen, P. Himanen et al. · British Journal of Clinical Pharmacology · 1986 · 68 citations · Full text

α-Adrenoceptor Blockade by Phentolamine Causes β-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic α-Blockade

Maythem Saeed, Olaf Sommer, J. Holtz et al. · Journal of Cardiovascular Pharmacology · 1982 · 64 citations

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +17

Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.

D Torvik, H-P. Madsbu · British Journal of Clinical Pharmacology · 1986 · 63 citations · Full text

The antihypertensive effects of doxazosin: a clinical overview.

DA Cox, JP Leader, JA Milson et al. · British Journal of Clinical Pharmacology · 1986 · 63 citations · Full text